Please try another search
Gennex Laboratories Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 335.03 million compared to INR 186.57 million a year ago. Revenue was INR 355.23 million compared to INR 207.99 million a year ago. Net income was INR 44.95 million compared to INR 20.37 million a year ago. Basic earnings per share from continuing operations was INR 0.158 compared to INR 0.117 a year ago. Diluted earnings per share from continuing operations was INR 0.144 compared to INR 0.117 a year ago. Basic earnings per share was INR 0.158 compared to INR 0.117 a year ago. Diluted earnings per share was INR 0.144 compared to INR 0.117 a year ago.For the full year, sales was INR 867.14 million compared to INR 656.03 million a year ago. Revenue was INR 916.2 million compared to INR 695.57 million a year ago. Net income was INR 131.75 million compared to INR 49.21 million a year ago. Basic earnings per share from continuing operations was INR 0.666 compared to INR 0.351 a year ago. Diluted earnings per share from continuing operations was INR 0.608 compared to INR 0.319 a year ago. Basic earnings per share was INR 0.666 compared to INR 0.319 a year ago. Diluted earnings per share was INR 0.608 compared to INR 0.319 a year ago.
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Revenue | 191.34 | 175.79 | 164.88 | |
Gross Profit | 88.44 | 72.31 | 103.04 | 114.74 |
Operating Income | 40.16 | 20.7 | 41.38 | 44.19 |
Net Income | 27.65 | 30.66 | 28.5 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Assets | 1322.55 | |||
Total Liabilities | 395.4 | |||
Total Equity | 927.15 | 865.15 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | ||||
Cash From Investing Activities | ||||
Cash From Financing Activities | ||||
Net Change in Cash |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review